Onset of psoriasis induced by infliximab

Journal of Clinical Rheumatology

Volumn 14, Issue 2, 2008, Pages 128-129

  Bal, Ajda ^a   Gurcay, Eda ^a   Aydog, Ece ^a   Umay, Ebru ^a   Tatlican, Semih ^b   Cakci, Aytul ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; INFLIXIMAB; METHOTREXATE; STEROID;

ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DRUG WITHDRAWAL; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42049121252     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31816b95d4     Document Type: Letter

References (7)

1. Goncalves DP, Laurindo I, Scheinberg MA. The appearance of pustular psoriasis during antitumor necrosis factor therapy. J Clin Rheumatol. 2006;12:262.
2. Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol. 2006;54:67-80.
3. Devos SA, Van Den Bossche N, De Vos M, et al. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology. 2003;206:388-390.
4. Chan AT, Cleeve V, Daymond TJ. Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis. Postgrad Med J. 2002;78:47-48.
5. Sari I, Akar S, Birlik M, et al. Anti-tumor necrosis factor-alpha-induced psoriasis. J Rheumatol. 2006;33:1411-1414.
6. Sfikakis PP, Iliopoulos A, Elezoglou A, et al. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 2005;52:2513-2518.
7. Starmans-Kool MJ, Peeters HR, Houben HH. Pustular skin lesions in patients treated with infliximab: report of two cases. Rheumatol Int. 2005;25:550-552.